EXECUTIVE SUMMARY EXECUTIVE SUMMARY 2 6M’18 6M’19 change Q2’18 Q1’19 Q2’19 change change Btmn Btmn y-on-y Btmn Btmn Btmn y-on-y q-on-q Sales and service income 16,961 21,123 24.5% 8,805 10,257 10,866 23.4
granted a license from China Food and Drug Administration (CFDA) during the beginning of 2018 as the Company had to redesign and adjust product packaging according to the granted license as well as change
Consolidated financial statements Change Increase/(Decrease) For Three Months Period Ended 30 September 2017 2018 THB mm % THB mm % THB mm % Sale Revenue Revenue from selling product under Company’s trademark 1
–2021 Balance by Quarter Change Q2–21 Q1–21 Q2–20 Q2–21 VS Q1–21 Q2–21 VS Q2–20 (Million Baht: MB) (MB) % (MB) % Total revenue 2,081.2 1,824.2 1,187.6 257.0 14.1 893.6 75.2 Total operating expenses
รายงานการประชุมคณะกรรมการตรวจสอบ ครั้งที่ 4/2548 Ref. No.: SET-2017-025 December 14, 2017 Subject: Transaction concerning Acquisition and Disposal of Assets Attn. To: President The Stock Exchange of
รายงานการประชุมคณะกรรมการตรวจสอบ ครั้งที่ 4/2548 Ref. No.: SET-2017-025 December 14, 2017 Subject: Acquisition of Franchise 25 Branches from total 113 Branches from “Wuttisak” (Revised) Attn. To
[COMPANY NAME] Ref: EFORL IR018/2020 27 March 2020 Subject: The Resolutions of the Board of Directors to postpone the 2020 Annual General Meeting of Shareholders and cancellation of the agenda item
CONSTRUCTION EXECUTIVE SUMMARY EXECUTIVE SUMMARY 2 Q1’19 Q4’19 Q1’20 change change Btmn Btmn Btmn y-on-y q-on-q Sales and service income 10,257 11,258 11,223 9.4% (0.3%) EBITDA* 2,413 2,938 3,278 35.8% 11.6% Net
The financial expenses in 2017 were 16.91 million baht decreased from previous year which were at 7.77 million baht. Comparing in term of percent of revenues, the ratio is not much change. It was at
from prior year by Baht 801.9 million or 96.3% due following to: Description 2019 Million Baht 2018 Million Baht Change Million Baht Change (%) Revenue from real estate segment - 800.0 (800.0) (100.0